SynthesisWorld journal of gastroenterology2015

Infliximab is superior to other biological agents for treatment of active ulcerative colitis: A meta-analysis.

Wei-Qun Mei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.